Viewing Study NCT06306456


Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2025-12-25 @ 9:24 PM
Study NCT ID: NCT06306456
Status: RECRUITING
Last Update Posted: 2024-07-08
First Post: 2024-02-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Sponsor: Suzhou Genhouse Bio Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module